Browse by Nurse Practitioner Items
Nurse practitioner PBS prescribing
PHARMACEUTICAL BENEFITS WHICH MAY BE PRESCRIBED BY AUTHORISED NURSE PRACTITIONERS
Nurse practitioners endorsed to prescribe under state or territory legislation can apply for approval as PBS prescribers (authorised nurse practitioners). Information for nurse practitioners to become authorised PBS prescribers is available from Services Australia.
The pharmaceutical benefits listed for prescribing by authorised nurse practitioners are identified by ‘NP’ in the PBS Schedule. Nurse practitioners must not issue PBS prescriptions for pharmaceutical benefits that do not specify ‘NP’ in the listing.
PBS prescribing is limited by a nurse practitioner’s scope of practice, adherence to professional practice standards as set by the Nursing and Midwifery Board of Australia, and state or territory prescribing rights. Prescribing of PBS medicines is also contingent on a prescriber being an authorised nurse practitioner as required by the National Health Act 1953.
The Pharmaceutical Benefits Advisory Committee (PBAC) is responsible for making recommendations to the Minister for Health and Aged Care regarding which medicines will attract a PBS subsidy when prescribed by authorised nurse practitioners.
Further to prescribing within an individual’s scope of practice, certain medicines have additional conditions for prescribing by nurse practitioners, as recommended by the PBAC. Authorised nurse practitioners should check the details of individual pharmaceutical benefits listings to ensure that all specified circumstances are met.
Some medicines are included in more than one section of the Schedule and for more than one prescriber type. For a prescription to be eligible for subsidy, authorised nurse practitioners must ensure that they prescribe under the PBS listing that specifies ‘NP’, and in accordance with any restrictions specified in that listing. Listing details for the same product may differ between sections of the Schedule and different PBS item codes apply for each prescriber type.
Nurse practitioner PBS prescriptions are identifiable by colour and include the indicator ‘NP’ on personalised forms and a tick box on non-personalised (blank) forms. Prescriptions must include the nurse practitioner’s PBS prescriber number. For unrestricted and restricted PBS medicines, nurse practitioners can use the personalised or non-personalised PBS prescriber forms. For authority required and authority required (streamlined) PBS medicines, nurse practitioners can use the authority personalised or non-personalised PBS prescriber forms. Nurse practitioner PBS prescriptions may include repeats.
Regulation 49 applies for nurse practitioner prescribing. A nurse practitioner can direct that original and repeat supplies of pharmaceutical benefits be supplied at the one time, if certain conditions are satisfied.
Authority prescriptions: Authority prescriptions for authority required items, or for increased quantities or repeats, require prior approval from Services Australia for each prescription. (Refer to Prescribing Medicines — Information for PBS prescribers for more information on authority prescriptions.)
State and territory requirements: Nurse practitioners may prescribe medicines as non-PBS (private) prescriptions provided that any prescribing is within the individual nurse practitioner’s scope of practice and any limitations declared through state or territory law. The medicines which can be prescribed differ between states and territories. It is the nurse practitioner’s responsibility to ensure adherence to state/territory law for all prescriptions (PBS and private) and additionally to all PBS requirements for PBS prescriptions.
- Legend
- PPalliative care items
- MPMedical Practitioner
- MWMidwife
- NPNurse Practitioner
- 60D60-day prescriptions
Prescriber code | Item code | Name, manner of administration and form & strength | Max qty packs |
Max qty units |
No. of repeats |
---|---|---|---|---|---|
MPNP | 11078C | NALOXONEnaloxone hydrochloride 1 mg/mL injection, 2 mL syringe | 1 | 1 | 0 |
MPNP | 11817Y | NALOXONEnaloxone 1.8 mg/actuation nasal spray, 2 x 1 actuation | 1 | 1 | 0 |
MPNP | 10783M | NALOXONEnaloxone hydrochloride 400 microgram/mL injection, 5 x 1 mL ampoules | 1 | 5 | 0 |
MPNP | 10786Q | NALOXONEnaloxone hydrochloride 400 microgram/mL injection, 5 x 1 mL ampoules | 2 | 10 | 0 |
MPNP | 11233F | NALOXONEnaloxone hydrochloride 400 microgram/mL injection, 10 x 1 mL ampoules | 1 | 10 | 0 |
MPNP | 8370M | NALTREXONEnaltrexone hydrochloride 50 mg tablet, 30 | 1 | 30 | 1 |
MPNP | 1615B | NAPROXENnaproxen 1 g modified release tablet, 28 | 1 | 28 | 3 |
MPNP | 5348L | NAPROXENnaproxen 1 g modified release tablet, 28 | 1 | 28 | 3 |
MPNP | 1674D | NAPROXENnaproxen 250 mg tablet, 50 | 2 | 100 | 3 |
MPNP | 5345H | NAPROXENnaproxen 250 mg tablet, 50 | 2 | 100 | 3 |
MPNP | 1795L | NAPROXENnaproxen sodium 550 mg tablet, 50 | 1 | 50 | 3 |
MPNP | 5353R | NAPROXENnaproxen sodium 550 mg tablet, 50 | 1 | 50 | 3 |
MPNP | 1614Y | NAPROXENnaproxen 750 mg modified release tablet, 28 | 1 | 28 | 3 |
MPNP | 5347K | NAPROXENnaproxen 750 mg modified release tablet, 28 | 1 | 28 | 3 |
MPNP | 1658G | NAPROXENnaproxen 125 mg/5 mL oral liquid, 474 mL | 1 | 1 | 3 |
MPNP | 5397C | NAPROXENnaproxen 125 mg/5 mL oral liquid, 474 mL | 1 | 1 | 3 |
MPNP | 8298R | NARATRIPTANnaratriptan 2.5 mg tablet, 2 | 2 | 4 | 5 |
MPNP | 9734H | NARATRIPTANnaratriptan 2.5 mg tablet, 2 | 2 | 4 | 5 |
MPNP | 13568D | NEBIVOLOLnebivolol 1.25 mg tablet, 28 | 4 | 112 | 5 |
MPNP | 9316H | NEBIVOLOLnebivolol 1.25 mg tablet, 28 | 2 | 56 | 5 |
MPNP | 13441K | NEBIVOLOLnebivolol 10 mg tablet, 28 | 2 | 56 | 5 |
MPNP | 9312D | NEBIVOLOLnebivolol 10 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 13510C | NEBIVOLOLnebivolol 5 mg tablet, 28 | 2 | 56 | 5 |
MPNP | 9311C | NEBIVOLOLnebivolol 5 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 10731T | NETUPITANT + PALONOSETRONnetupitant 300 mg + palonosetron 500 microgram capsule, 1 | 1 | 1 | 5 |
MPNP | 10319D | NEVIRAPINEnevirapine 10 mg/mL oral liquid, 240 mL | 10 | 10 | 5 |
MPNP | 10304H | NEVIRAPINEnevirapine 200 mg tablet, 60 | 2 | 120 | 5 |
MPNP | 10303G | NEVIRAPINEnevirapine 400 mg modified release tablet, 30 | 2 | 60 | 5 |
MPNP | 13550E | NICORANDILnicorandil 10 mg tablet, 60 | 2 | 2 | 5 |
MPNP | 8228C | NICORANDILnicorandil 10 mg tablet, 60 | 1 | 1 | 5 |
MPNP | 13551F | NICORANDILnicorandil 20 mg tablet, 60 | 2 | 2 | 5 |
MPNP | 8229D | NICORANDILnicorandil 20 mg tablet, 60 | 1 | 1 | 5 |
MPNP | 10076H | NICOTINEnicotine 25 mg/16 hours patch, 28 | 1 | 28 | 2 |
MPNP | 5572G | NICOTINEnicotine 14 mg/24 hours patch, 28 | 1 | 28 | 2 |
MPNP | 3414Q | NICOTINEnicotine 21 mg/24 hours patch, 28 | 1 | 28 | 2 |
MPNP | 5465P | NICOTINEnicotine 21 mg/24 hours patch, 28 | 1 | 28 | 2 |
MPNP | 5571F | NICOTINEnicotine 21 mg/24 hours patch, 28 | 1 | 28 | 2 |
MPNP | 5573H | NICOTINEnicotine 7 mg/24 hours patch, 28 | 1 | 28 | 2 |
MPNP | 13502P | NIFEDIPINEnifedipine 30 mg modified release tablet, 30 | 2 | 60 | 5 |
MPNP | 1906H | NIFEDIPINEnifedipine 30 mg modified release tablet, 30 | 1 | 30 | 5 |
MPNP | 13376B | NIFEDIPINEnifedipine 60 mg modified release tablet, 30 | 2 | 60 | 5 |
MPNP | 1907J | NIFEDIPINEnifedipine 60 mg modified release tablet, 30 | 1 | 30 | 5 |
MPNP | 12996B | NIRMATRELVIR (&) RITONAVIRnirmatrelvir 150 mg tablet [4] (&) ritonavir 100 mg tablet [2], 5 x 6 | 1 | 1 | 0 |
MPNP | 13147Y | NIRMATRELVIR (&) RITONAVIRnirmatrelvir 150 mg tablet [4] (&) ritonavir 100 mg tablet [2], 5 x 6 | 2 | 2 | 0 |
MPNP | 2723H | NITRAZEPAMnitrazepam 5 mg tablet, 25 | 1 | 25 | 0 |
MPNP | 2732T | NITRAZEPAMnitrazepam 5 mg tablet, 25 | 2 | 50 | 5 |
MPNP | 5359C | NITRAZEPAMnitrazepam 5 mg tablet, 25 | 2 | 50 | 3 |
MPMWNP | 1693D | NITROFURANTOINnitrofurantoin 100 mg capsule, 30 | 1 | 30 | 1 |
MPMWNP | 1692C | NITROFURANTOINnitrofurantoin 50 mg capsule, 30 | 1 | 30 | 1 |
MPNP | 14306Y | NIZATIDINEnizatidine 150 mg capsule, 60 | 2 | 120 | 5 |
MPNP | 1505F | NIZATIDINEnizatidine 150 mg capsule, 60 | 1 | 60 | 5 |
MPNP | 14372K | NIZATIDINEnizatidine 300 mg capsule, 30 | 2 | 60 | 5 |
MPNP | 1504E | NIZATIDINEnizatidine 300 mg capsule, 30 | 1 | 30 | 5 |
MPNP | 1967M | NORETHISTERONEnorethisterone 350 microgram tablet, 4 x 28 | 1 | 4 | 2 |
MPNP | 13873E | NORETHISTERONEnorethisterone 5 mg tablet, 30 | 2 | 60 | 2 |
MPNP | 2993M | NORETHISTERONEnorethisterone 5 mg tablet, 30 | 1 | 30 | 2 |
MPNP | 2775C | NORETHISTERONE + ETHINYLESTRADIOLnorethisterone 1 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 4 x 28 | 1 | 4 | 2 |
MPNP | 2774B | NORETHISTERONE + ETHINYLESTRADIOLnorethisterone 500 microgram + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 4 x 28 | 1 | 4 | 2 |
MPNP | 3010K | NORFLOXACINnorfloxacin 400 mg tablet, 14 | 1 | 14 | 1 |
MPNP | 2522R | NORTRIPTYLINEnortriptyline 10 mg tablet, 50 | 1 | 50 | 2 |
MPNP | 2523T | NORTRIPTYLINEnortriptyline 25 mg tablet, 50 | 1 | 50 | 2 |
MPNP | 1699K | NYSTATINnystatin 500 000 units capsule, 50 | 1 | 50 | 0 |
MPNP | 1696G | NYSTATINnystatin 500 000 units tablet, 50 | 1 | 50 | 0 |